Flexible linkers in CaMKII control the balance between activating and inhibitory autophosphorylation.
Moitrayee BhattacharyyaYoung Kwang LeeSerena MuratciogluBaiyu QiuPriya NyayapatiHoward SchulmanJay T GrovesJohn KuriyanPublished in: eLife (2020)
The many variants of human Ca2+/calmodulin-dependent protein kinase II (CaMKII) differ in the lengths and sequences of disordered linkers connecting the kinase domains to the oligomeric hubs of the holoenzyme. CaMKII activity depends on the balance between activating and inhibitory autophosphorylation (on Thr 286 and Thr 305/306, respectively, in the human α isoform). Variation in the linkers could alter transphosphorylation rates within a holoenzyme and the balance of autophosphorylation outcomes. We show, using mammalian cell expression and a single-molecule assay, that the balance of autophosphorylation is flipped between CaMKII variants with longer and shorter linkers. For the principal isoforms in the brain, CaMKII-α, with a ~30 residue linker, readily acquires activating autophosphorylation, while CaMKII-β, with a ~200 residue linker, is biased towards inhibitory autophosphorylation. Our results show how the responsiveness of CaMKII holoenzymes to calcium signals can be tuned by varying the relative levels of isoforms with long and short linkers.
Keyphrases
- protein kinase
- single molecule
- endothelial cells
- signaling pathway
- poor prognosis
- copy number
- stem cells
- induced pluripotent stem cells
- metabolic syndrome
- pluripotent stem cells
- living cells
- high throughput
- white matter
- blood brain barrier
- amino acid
- cell therapy
- resting state
- tyrosine kinase
- multiple sclerosis
- binding protein